China Pharma Balance Sheet - Quarterly (NYSEMKT:CPHI)

Add to My Stocks
$0.2 $0.01 (4.76%) CPHI stock closing price Sep 25, 2018 (Closing)

The financial analysis of a company like China Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. Financial strength can be guaged by performing China Pharma stock analysis and by analyzing the balance sheet. A company releases its balance sheet every quarter along with its quarterly results. China Pharma had a long term debt of $6.79M at the end of 2018 Q2. To understand the debt servicing capacity of the company, one needs to look at China Pharma operating cash flow and China Pharma revenue also. China Pharma debt to equity ratio is 0.26.

View and download China Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials4.8M4.55M4.73M10.87M10.85M10.79M11.56M12.1M12.18M12.32M
Work In Progress----------
Finished Goods1.32M1.25M1.19M1.83M1.67M1.39M1.53M2.73M3.12M3.66M
Notes Receivable----------
Other Current Assets---2.55M2.24M2.24M2.23M2.87M2.81M2.83M
Total Current Assets
Property Plant & Equipment38.42M40.47M39.06M38.76M37.41M36.77M36.46M37.86M37.98M39.11M
Accumulated Depreciation16.84M16.91M15.52M14.61M13.33M12.35M11.5M11.52M10.77M10.28M
Net Property Plant & Equipment
Investment & Advances23.31M24.57M23.72M35.41M35.38M35.77M35.49M39.45M40.25M42.3M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable-1.08M4.62M4.88M4.9M4.76M3.93M3.78M3.8M2.48M
Accounts Payable1.15M1.37M1.14M1.89M2.14M2.87M3.06M3.47M2.86M3.74M
Current Portion Long-Term Debt2.11M2.22M2.3M2.29M1.32M1.44M1.44M1.49M1.5M1.55M
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities4.62M4.59M4.79M4.5M4.3M4.41M4.66M4.16M3.92M3.99M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt6.79M7.16M6.91M6.87M8.85M8.57M8.64M8.99M10.23M10.54M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus23.59M23.59M23.59M23.59M23.59M23.59M23.59M23.59M23.59M23.59M
Retained Earnings4.17M5.18M5.47M19.3M21.5M23.79M24.75M28.18M29.93M32.38M
Treasury Stock----------
Other Liabilities13.21M15.63M13.95M14.08M12M10.99M10.51M13.11M13.39M15.54M
Shareholders Equity41.02M44.45M43.07M57.03M57.14M58.42M58.9M64.93M66.96M71.56M
Total Liabilities & Shareholders Equity58.3M62.12M59.95M74.99M77.12M78.14M78.52M87.4M91.97M97.03M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Mylan financial analysis

Looking at China Pharma historical stock prices and the current China Pharma stock price can tell you how the stock price has moved, whereas the China Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the China Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. China Pharma had total assets of $58.3M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for China Pharma is $17.28M. Shareholders equity comes under liabilities as it is money the company owes the holders of CPHI stock.

China Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio